ZA942809B - Treatment - Google Patents
TreatmentInfo
- Publication number
- ZA942809B ZA942809B ZA942809A ZA942809A ZA942809B ZA 942809 B ZA942809 B ZA 942809B ZA 942809 A ZA942809 A ZA 942809A ZA 942809 A ZA942809 A ZA 942809A ZA 942809 B ZA942809 B ZA 942809B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939308802A GB9308802D0 (en) | 1993-04-28 | 1993-04-28 | Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA942809B true ZA942809B (en) | 1995-10-23 |
Family
ID=10734635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA942809A ZA942809B (en) | 1993-04-28 | 1994-04-22 | Treatment |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU6569794A (en) |
GB (1) | GB9308802D0 (en) |
WO (1) | WO1994025012A2 (en) |
ZA (1) | ZA942809B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5677321A (en) * | 1996-02-29 | 1997-10-14 | Synaptic Pharmaceutical Corporation | 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands |
GB9700899D0 (en) * | 1997-01-17 | 1997-03-05 | Smithkline Beecham Plc | Novel treatment |
EP1158985B1 (en) | 1999-01-13 | 2011-12-28 | Bayer HealthCare LLC | OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
AU2003209118A1 (en) | 2002-02-11 | 2003-09-04 | Bayer Pharmaceuticals Corporation | Aryl ureas as kinase inhibitors |
EP1478358B1 (en) | 2002-02-11 | 2013-07-03 | Bayer HealthCare LLC | Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis |
CA2526636C (en) | 2003-05-20 | 2012-10-02 | Bayer Pharmaceuticals Corporation | Diaryl ureas for diseases mediated by pdgfr |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0550507A1 (en) * | 1990-09-13 | 1993-07-14 | Beecham Group p.l.c. | Indole ureas as 5 ht receptor antagonist |
WO1993018026A1 (en) * | 1992-03-04 | 1993-09-16 | Beecham Group Plc | Indole ureas as 5-ht1c receptor antogonists |
WO1993018028A1 (en) * | 1992-03-12 | 1993-09-16 | Smithkline Beecham Plc | Indole derivatives as 5ht1c antagonists |
-
1993
- 1993-04-28 GB GB939308802A patent/GB9308802D0/en active Pending
-
1994
- 1994-04-20 WO PCT/EP1994/001240 patent/WO1994025012A2/en active Application Filing
- 1994-04-20 AU AU65697/94A patent/AU6569794A/en not_active Abandoned
- 1994-04-22 ZA ZA942809A patent/ZA942809B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994025012A3 (en) | 1994-12-22 |
GB9308802D0 (en) | 1993-06-09 |
AU6569794A (en) | 1994-11-21 |
WO1994025012A2 (en) | 1994-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9411080D0 (en) | Treatment | |
GB9215633D0 (en) | Novel treatment | |
GB9226860D0 (en) | Novel treatment | |
GB9203039D0 (en) | Treatment | |
GB9211148D0 (en) | Novel treatment | |
GB9225860D0 (en) | Novel treatment | |
GB9226957D0 (en) | Novel treatment | |
ZA942809B (en) | Treatment | |
GB9226958D0 (en) | Produktionsaktieselskab) novel treatment | |
GB2274395B (en) | Massager | |
ZA933376B (en) | Novel treatment | |
GB9203637D0 (en) | Novel treatment | |
GB9317306D0 (en) | Effluent treatment | |
ZA948336B (en) | Treatment | |
GB9310836D0 (en) | Treatment | |
GB9225859D0 (en) | Novel treatment | |
GB9314491D0 (en) | Novel treatment | |
GB9210596D0 (en) | Treatment | |
GB9200361D0 (en) | Treatment | |
GB9200359D0 (en) | Treatment | |
GB9215903D0 (en) | Treatment | |
GB9206395D0 (en) | Treatment | |
GB9203249D0 (en) | Treatment | |
GB9200360D0 (en) | Treatment | |
GB9321592D0 (en) | Novel compounds and treatment |